Stock Research: Medartis Holding

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Medartis Holding

SWX:MED CH0386200239
50
  • Value
    54
  • Growth
    87
  • Safety
    Safety
    9
  • Combined
    50
  • Sentiment
    43
  • 360° View
    360° View
    50
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Medartis Holding AG is a Switzerland-based medical device company manufacturing implants for fracture fixation. They operate in the medical devices and implants industry with product lines like APTUS (upper and lower extremities) and MODUS (cranio-maxillofacial surgery). Their products are sold globally in over 30 countries, including Germany and the United States. In the last fiscal year, the company had a market cap of $1349 million, profits of $197 million, revenue of $248 million, and 949 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 50 (better than 50% compared with alternatives), overall professional sentiment and financial characteristics for the stock Medartis Holding are above average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Medartis Holding. The consolidated Growth Rank has a good rank of 87, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 87% of competitors in the same industry. In addition, the consolidated Safety Rank has a safer rank of 54 which means that the company has a financing structure that is safer than 54% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the consolidated Value Rank has a less desirable rank of 9 which means that the share price of Medartis Holding is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is higher than for 91% of alternative stocks in the same industry. The consolidated Sentiment Rank also has a low rank of 43, which means that professional investors are more pessimistic about the stock than for 57% of alternative investment opportunities. ...read more

more
Index
SPI
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 16-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
9 16 17 5
Growth
87 82 85 93
Safety
Safety
54 86 57 56
Sentiment
43 14 65 58
360° View
360° View
50 51 72 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
34 57 88 17
Opinions Change
50 28 50 92
Pro Holdings
n/a 16 42 45
Market Pulse
51 35 44 56
Sentiment
43 14 65 58
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
9 16 17 5
Growth
87 82 85 93
Safety Safety
54 86 57 56
Combined
50 76 57 58
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
1 3 9 3
Price vs. Earnings (P/E)
33 37 38 16
Price vs. Book (P/B)
35 37 34 32
Dividend Yield
1 1 1 1
Value
9 16 17 5
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
98 79 86 80
Profit Growth
4 100 100 98
Capital Growth
87 19 43 24
Stock Returns
83 56 35 100
Growth
87 82 85 93
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
46 67 80 78
Refinancing
81 76 49 55
Liquidity
25 74 25 23
Safety Safety
54 86 57 56

Similar Stocks

Discover high‑ranked alternatives to Medartis Holding and broaden your portfolio horizons.

ALSO

SWX:ALSN
Country: Switzerland
Industry: Technology Distributors
Size: Medium
Full Stock Analysis

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

DKSH

SWX:DKSH
Country: Switzerland
Industry: Research & Consulting
Size: Large
Full Stock Analysis

Smith & Nephew

LSE:SN.
Country: United Kingdom
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.